Lipoprotein lipase activity is associated with severity of angina pectoris

Circulation

Volumn 102, Issue 14, 2000, Pages 1629-1633

  Kastelein, John J P ^a   Jukema, J Wouter ^b,c   Zwinderman, Aeilko H ^b,c   Clee, Suzanne ^g   Van Boven, Ad J ^d   Jansen, Hans ^e   Rabelink, Ton J ^f   Peters, Ron J G ^a   Lie, Kong I ^a   Liu, George ^h   Bruschke, Albert V G ^b,c   Hayden, Michael R ^g  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h Department of Vascular Medicine ^*

Author keywords

Angina; Ischemia; Lipoproteins

Indexed keywords

HEPARIN; LIPOPROTEIN; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CATALYSIS; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034601745     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.14.1629     Document Type: Article

References (38)

1. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies
2. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction
3. Echo-lucency of computerized ultrasound images of carotid atherosclerotic plaques is associated with increased levels of triglyceride-rich lipoproteins as well as increased lipid content
4. Stability and instability: Two faces of coronary atherosclerosis: The Paul Dudley White Lecture
5. Nitric oxide activity in the human coronary circulation
6. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans
7. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects
8. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease
9. Remnant lipoproteins impair endothelium-dependent vasomotor functions in human coronary arteries
10. Serum levels of remnant like particles: Cholesterol affects the endothelium dependent coronary vascular response in humans
11. Effect of a single high fat meal on endothelial function in healthy subjects
12. High fat meal induces changes in blood theology in patients with coronary artery disease
13. Triglyceride-rich lipoproteins and progression of coronary artery disease
14. Familial lipoprotein lipase deficiency and other causes of the chylomironemia syndrome
15. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene
16. 9Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis
17. Genetic variant showing a positive interaction with β-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients
18. Prevalence of common lipoprotein lipase (LPL) gene mutation Ser447stop is increased while prevalence of Asn2911Ser mutation is decreased in centenarians
19. A common truncation variant of lipoprotein lipase (S447X) confers protection against coronary heart disease: The Framingham Offspring Study
20. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: The Regression Growth Evaluation Statin Study (REGRESS)
21. A stable, radioactive substrate emulsion for assay of lipoprotein lipase
22. Reduction of transient myocardial ischemia with pravastatin additional to the convenient treatment in patients with angina pectoris
23. Transport of lipoprotein lipase in plasma and lipoprotein metabolism
24. Effect of increased afterload on cardiac lipoprotein lipase and VLDL receptor expression
25. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis
26. The Asn9 variant of lipoprotein is associated with the -93G promotor mutation and an increased risk of coronary artery disease
27. Triglycerides and cardiovascular disease
28. Triglyceride-rich lipoproteins and progression of atherosclerosis
29. No activity in familial combined hyperlipidemia: Potential role of cholesterol remnants
30. Altered myocardial vasodilation in patients with hypertriglyceridemia in anatomically normal coronary disease
31. Postprandial lipemia and chylomicron clearance in athletes and in sedentary men
32. A frequently occurring mutation in the lipoprotein lipase gene (Ash291Ser) results in altered postprandial chylomicron triglyceride and retinyl pulmitate response in normolipidemic carriers
33. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels
34. Lipoprotein synergizes with interferon gamma to induce macrophage nitric oxide synthetase mRNA expression and nitric oxide production
35. Lipoprotein lipase activity in ischemic and anoxic myocardium
36. Antiatherogenic effects of a novel lipoprotein lipase-enhancing agent in cholesterol-fed New Zealand white rabbits
37. The novel compound NO-1886 increases lipoprotein activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atherosclerosis
38. Effect of troglitazone on plasma lipid metabolism and lipoprotein lipase